7073 results for "canc*"
in 86.40 milliseconds.
-
Colorectal Cancer Organoids Data Access Committee
Dac EGAC00001000998 -
Genome-wide association study of cervical cancer in East Asian populations
Dac EGAC00001001024 -
Data Access Commitee for gastric cancer ascites
Dac EGAC00001001026 -
Rectal Cancer Samples Data Access Committee
Dac EGAC00001001034 -
University of Florida Brain Cancer DAC
Dac EGAC00001001035 -
University Clinic Erlangen/ German Cancer Research Center rare tumors data access committee
Dac EGAC00001001053 -
Age-related remodeling of apparently normal esophageal epithelia by common cancer drivers
Dac EGAC00001001067 -
SNP array datas of "Matched" cancer/PNE
Dac EGAC00001001069 -
DAC for study: Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer
Dac EGAC00001001082 -
DAC for Familial Breast Cancer study EGAS00001003305
Dac EGAC00001001087 -
DAC for study Non-coding RNAs in Breast Cancer
Dac EGAC00001001090 -
DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"
Dac EGAC00001001099 -
DAC for Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Dac EGAC00001001101 -
Radboudumc Cancer Genomics DAC
Dac EGAC00001001102 -
DAC for MCO colorectal cancer genomics at UNSW
Dac EGAC00001001122 -
DAC for Genomic characterization of metastatic breast cancers
Dac EGAC00001001129 -
Korean Advanced Thyroid Cancer Data Access Commitee
Dac EGAC00001001151 -
DAC for GAMuT Project - Peter MacCallum Cancer Centre
Dac EGAC00001001154 -
Leeds Cancer Genomics
Dac EGAC00001001156 -
Children's Cancer Therapy Development Institute Data Access Commitee
Dac EGAC00001001160 -
Stanford Data Access Committee for Multi-Region WES of Metastatic Colorectal Cancer
Dac EGAC00001001164 -
Charbonneau Cancer Institute DAC
Dac EGAC00001001165 -
The data access committee for genome-wide cell-free DNA fragmentation in patients with cancer
Dac EGAC00001001180 -
OSBREAC (Oslo Breast Cancer Research Consortium)
Dac EGAC00001001186 -
Latency and interval therapy affect the evolution in metastatic colorectal cancer.
Dac EGAC00001001198
